Zdrowie i gospodarka · 21/04/2003

FDA Releases Draft Guidance for Multiplex Tests in Heritable DNA Markers, Mutations, and Expression Patterns

The Food and Drug Administration (FDA) has released a draft guidance document for the industry and FDA reviewers on multiplex tests for heritable DNA markers, mutations, and expression patterns. The document aims to provide clarity on the types of data required for submissions, supporting the timely review and marketing of safe and effective products utilizing this technology.